Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
LSE - Delayed Quote GBp

Cambridge Nutritional Sciences plc (CNSL.L)

Compare
2.7500
-0.2500
(-8.33%)
At close: April 4 at 2:27:02 PM GMT+1
Currency in GBP All numbers in thousands
Download
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
9,774
9,774
7,546
8,539
6,816
Cost of Revenue
3,728
3,728
4,001
3,437
2,820
Gross Profit
6,046
6,046
3,545
5,102
3,996
Operating Expense
6,581
6,581
6,260
5,694
4,464
Operating Income
-535
-535
-2,715
-592
-468
Net Non Operating Interest Income Expense
28
28
-13
-21
-78
Pretax Income
-745
-745
-3,252
-950
-546
Tax Provision
-417
-417
-80
459
-931
Net Income Common Stockholders
-328
-328
-3,860
-11,333
-2,104
Diluted NI Available to Com Stockholders
-328
-328
-3,860
-11,333
-2,104
Basic EPS
-0.01
-0.00
-0.02
-0.06
-0.01
Diluted EPS
-0.01
-0.00
-0.02
-0.06
-0.01
Basic Average Shares
237,384.6180
237,727.1360
231,263.8840
182,638.4270
171,688.7300
Diluted Average Shares
237,959.6180
238,097.1360
231,838.8840
186,998.0800
177,104.1790
Total Operating Income as Reported
-535
-535
-2,715
-592
-468
Rent Expense Supplemental
10
10
17
15
6
Total Expenses
10,309
10,309
10,261
9,131
7,284
Net Income from Continuing & Discontinued Operation
-328
-328
-3,860
-11,333
-2,104
Normalized Income
-149.5000
-149.5000
-2,660.8905
-1,136.0300
385
Interest Income
50
50
--
--
--
Interest Expense
22
22
13
21
78
Net Interest Income
28
28
-13
-21
-78
EBIT
-723
-723
-3,239
-929
-468
EBITDA
-73
-73
-2,648
360
418
Reconciled Cost of Revenue
3,728
3,728
4,001
3,437
2,820
Reconciled Depreciation
650
650
591
1,289
886
Net Income from Continuing Operation Net Minority Interest
-328
-328
-3,172
-1,409
385
Total Unusual Items Excluding Goodwill
-238
-238
-524
-337
--
Total Unusual Items
-238
-238
-524
-337
--
Normalized EBITDA
165
165
-2,124
697
418
Tax Rate for Calcs
0.0003
0.0003
0
0.0002
0.0002
Tax Effect of Unusual Items
-59.5000
-59.5000
-12.8905
-64.0300
--
3/31/2021 - 3/19/2004

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade